The RLIP76 N-terminus binds ARNO to regulate PI 3-kinase, Arf6 and Rac signaling, cell spreading and migration

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• RLIP76 is a key protein in tumor growth and angiogenesis.
• RLIP76 is a potential therapeutic target for various cancers.
• RLIP76 interacts with ARNO, a guanine nucleotide exchange factor for Arf6.

Purpose of the Study:

• To investigate the role of RLIP76 N-terminal domain in ARNO interaction.
• To elucidate the mechanism by which RLIP76 regulates cell spreading and migration.
• To identify specific sites in RLIP76 N-terminus affecting ARNO binding and downstream signaling.

Main Methods:

• Site-directed mutagenesis of RLIP76 N-terminal serine residues (Ser29/Ser30 and Ser62).
• Assessment of ARNO-RLIP76 interaction using co-immunoprecipitation.
• Analysis of Arf6 and Rac1 activation.
• Evaluation of PI3K activity.
• Cell spreading and migration assays.

Main Results:

• ARNO binds to the RLIP76 N-terminal domain, which is essential for RLIP76-mediated cell spreading and migration.
• Mutation of Ser29/Ser30 to Alanine abolished ARNO interaction and blocked RLIP76-dependent cell spreading, migration, and Arf6 activation.
• Mutation of Ser62 to Alanine (S62A) allowed ARNO interaction and Arf6 activation but blocked Rac1 activation.
• Both mutations blocked Rac1 activation, and RLIP76-mediated Arf6 and Rac1 activation required PI3K activity.
• S29/30A mutations inhibited RLIP76-dependent PI3K activation, while S62A mutation did not.

Conclusions:

• ARNO interaction with the RLIP76 N-terminus is critical for regulating cell spreading and motility.
• RLIP76 utilizes PI3K and Arf6 signaling pathways for cell motility, independent of its Rac1 regulation.
• Specific N-terminal sites on RLIP76 differentially modulate ARNO binding and downstream signaling, offering insights into cancer cell behavior.